Gilead Sciences Update On The Company’s Ongoing Production & Enhanced Distribution of Remdesivir Anti-Wuhan Virus Treatment

March 29, 2020

Gilead Sciences Inc. will distribute its Anti-Wuhan Super Virus drug Remdesivir to accelerate its emergency use for multiple severely ill patients.

Gilead is mapping out options to make access to investigational Remdesivir more widely available through expedited regulatory processes should it demonstrate the potential to be a safe and effective treatment option based on the results of preliminary clinical trials.


Read More:

Read More:

Please reload

Featured Posts

CLOWN WORLD: PEDO Joe's Latest Angry Speech's

October 26, 2020

Please reload

Recent Posts
Please reload

Please reload

Search By Tags

I'm busy working on my blog posts. Watch this space!

Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square





  • Facebook
  • Twitter
  • LinkedIn

©2018 by Delta News Hub. Proudly created with